Literature DB >> 12957571

The flow cytometric PKH-26 assay for the determination of T-cell mediated cytotoxic activity.

Karin Fischer1, Andreas Mackensen.   

Abstract

We present a rapid flow cytometric and non-radioactive functional assay developed for the determination of the cytotoxic activity of T lymphocytes, natural killer cells, and lymphokine-activated killer cells. In contrast to indirect evaluation of cytotoxicity using radioactive assays, this assay is based on the quantitative and qualitative flow cytometric analysis of cell damage on a single cell level. Target cells are stained with PKH-26, a lipophilic dye that stably integrates into the cell membrane, without disturbing its surface marker expression. It, thus, permits the distinction between target and effector cells. After short term in vitro incubation (1.5-3h), AnnexinV-FITC (ann-FITC) staining allows to discriminate between apoptotic and non-apoptotic target cells. Data analysis is performed first by gating on PKH-26 positive target cells, followed by the analysis of the ann-FITC positive subpopulation. The percentage of cytotoxicity in the PKH-26 gated cell population is calculated by subtracting unspecific ann-FITC positive target cells, measured in appropriate controls without effector cells. Using in vitro generated antigen-specific cytotoxic T lymphocytes, we demonstrate that this flow cytometric assay is sensitive, correlates well with the standard 51Cr release assay, and is easy to handle.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12957571     DOI: 10.1016/s1046-2023(03)00123-3

Source DB:  PubMed          Journal:  Methods        ISSN: 1046-2023            Impact factor:   3.608


  9 in total

1.  Induction of alloanergy in human donor T cells without loss of pathogen or tumor immunity.

Authors:  Jeffrey K Davies; Dongin Yuk; Lee M Nadler; Eva C Guinan
Journal:  Transplantation       Date:  2008-09-27       Impact factor: 4.939

2.  Killer artificial antigen-presenting cells: a novel strategy to delete specific T cells.

Authors:  Christian Schütz; Martin Fleck; Andreas Mackensen; Alessia Zoso; Dagmar Halbritter; Jonathan P Schneck; Mathias Oelke
Journal:  Blood       Date:  2007-12-20       Impact factor: 22.113

3.  Long-term protection from syngeneic acute lymphoblastic leukemia by CpG ODN-mediated stimulation of innate and adaptive immune responses.

Authors:  Alix E Seif; David M Barrett; Michael Milone; Valerie I Brown; Stephan A Grupp; Gregor S D Reid
Journal:  Blood       Date:  2009-07-27       Impact factor: 22.113

4.  Multiple functions of sushi domain containing 2 (SUSD2) in breast tumorigenesis.

Authors:  Allison P Watson; Rick L Evans; Kristi A Egland
Journal:  Mol Cancer Res       Date:  2012-11-06       Impact factor: 5.852

5.  Systemically transplanted mesenchymal stem cells induce vascular-like structure formation in a rat model of vaginal injury.

Authors:  Ofra Ben Menachem-Zidon; Michal Gropp; Etti Ben Shushan; Benjamin Reubinoff; David Shveiky
Journal:  PLoS One       Date:  2019-06-13       Impact factor: 3.240

6.  Long-term survival without graft-versus-host-disease following infusion of allogeneic myeloma-specific Vβ T cell families.

Authors:  S Yado; G Luboshits; O Hazan; R Or; M A Firer
Journal:  J Immunother Cancer       Date:  2019-11-14       Impact factor: 13.751

7.  Novel dual-fluorescent flow cytometric approach for quantification of macrophages infected with Leishmania infantum parasites.

Authors:  Zeynep Islek; Mehmet Hikmet Ucisik; Fikrettin Sahin
Journal:  Parasitology       Date:  2021-09-07       Impact factor: 3.234

8.  Measuring cytotoxicity by bioluminescence imaging outperforms the standard chromium-51 release assay.

Authors:  Mobin A Karimi; Eric Lee; Michael H Bachmann; Ana Maria Salicioni; Edward M Behrens; Taku Kambayashi; Cynthia L Baldwin
Journal:  PLoS One       Date:  2014-02-19       Impact factor: 3.240

9.  Effect of HSV-IL12 Loaded Tumor Cell-Based Vaccination in a Mouse Model of High-Grade Neuroblastoma.

Authors:  David F Bauer; Larisa Pereboeva; G Yancey Gillespie; Gretchen A Cloud; Osama Elzafarany; Catherine Langford; James M Markert; Lawrence S Lamb
Journal:  J Immunol Res       Date:  2016-08-17       Impact factor: 4.818

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.